<aside>
For Registered Dietitians providing telehealth MNT. Covers individualized, stigma-free nutrition care across the glycemic spectrum — lifestyle-only, oral/non-insulin medication, GLP-1/incretin therapy, and insulin-supported care.
</aside>
A practical, evidence-based learning resource for adult outpatient, telehealth-only MNT delivered by a registered dietitian across the glycemic spectrum, from prediabetes through established type 2 diabetes. It supports individualized, stigma-free care across lifestyle-only, oral or non-insulin injectable medication, GLP-1/incretin-based therapy, and insulin-supported pathways.
Use A1c or glucose trend, complication risk, medication regimen, hypoglycemia risk, nutrition status, patient priorities, and readiness to select the care pathway. Glycemic improvement is the central clinical target. Wweight change is not required to achieve meaningful benefit and should not be assumed to be the patient’s goal. This guide is not a substitute for specialty protocols, prescribing guidance, insulin titration algorithms, or individualized medical judgment.
Type 2 diabetes is a complex, chronic, progressive disease driven by insulin resistance and declining beta-cell function, and shaped by genetics, medications, sleep, stress, environment, social determinants, and behavior. Prediabetes reflects early, often reversible glycemic dysfunction and is a distinct opportunity for prevention, not a mild or lesser condition. Avoid explanations based on willpower or personal responsibility for either state.
A1c and glucose values are clinical measures, not measures of a patient’s effort, discipline, or worth. Interpret them alongside nutrition status, function, psychosocial context, and treatment regimen.
Discuss weight and detailed eating patterns based on the patient’s preference, and co-develop whether and how weight is used as a metric. It can be a meaningful outcome to track when the patient wants to include it, however glycemic and metabolic outcomes can equally be addressed through a weight-neutral approach when that is what the patient prefers instead.
MNT is an active, first-line component of care at every point on the glycemic spectrum, whether or not medications are also used.
Diagnosis of prediabetes or diabetes, medication selection and prescribing, insulin initiation and dose adjustment, interpretation of continuous glucose monitor (CGM) data for dosing decisions, management of hypoglycemia or hyperglycemia emergencies, diagnosis of complications, and treatment of comorbid conditions are outside RD scope unless separately licensed or credentialed. The RD assesses nutrition risk, delivers MNT, supports safe use of glucose data for food and behavior decisions, and monitors response. Labs and vital sign data used in this guide typically come from what the patient uploads or reports. As a telehealth-only service, the RD does not routinely communicate with the patient’s prescriber and may do so only when the patient has authorized and arranged that contact.